About US
Contact us
-
FIT Biotech to start trial of potential HIV vaccine this yearFinland-based FIT Biotech has developed a new vaccine for the treatment of human immunodeficiency virus (HIV). The new vaccine will be tested in hundreds of HIV patients in a large clinical trial, wh2014/1/7
-
Bayer's hot-selling Eylea runs into a roadblock in its home marketSales ofBayer'sEyleahave taken off since the EU greenlighted the eye drug in late in 2012. But now,Germany's cost watchdog has thrown up a roadblock for the second time. Thursday, the German Institute2014/1/6
-
GSK Adds Detailed Clinical Trial Data to Multi-Sponsor Request System as Part of Commitment to Data TransparencyGlaxoSmithKline (GSK) has added its anonymised patient-level data from the online request system it launched in May 2013 to a new multi-sponsor request system (clinicalstudydatarequest.com) that inclu2014/1/6
-
Genzyme Receives Complete Response Letter from FDA on Lemtrada (Alemtuzumab) ApplicationSanofi and its subsidiary Genzyme has received a Complete Response Letter from FDA for its supplemental Biologics License Application seeking approval of Lemtrada (alemtuzumab) for the treatment of re2014/1/3
-
China plans to blacklist drugmakers for bribery; violators will be suspendedIf China's pharma corruption probe hasn't spooked drugmakers enough, a new promise of punishment might. Chinese authorities say they will blacklist drugmakers caught bribing doctors and other health a2014/1/3
-
China suspends imports of Pfizer's AIDS-related drug on a paperwork problemForeign drugmakers have had their fair share of struggles inChinathis year as the country looked to cut down on healthcare spending and root outbribery. But neither of those factors caused a Tuesday h2014/1/2
-
Merck is cutting 150 in its Saphris sales team after selling the drug to Forest for $240MMerck ($MRK) early in December agreed to sell the rights to itsantipsychoticdrug Saphris to Forest Laboratories ($FRX) for $240 million. The move not only gave it a small cash boost, but it turns out2014/1/2
-
CFDA Minister Zhang Yong meets Minister of Food and Drug Safety of the Republic of KoreaOn December 19, 2013, Zhang Yong, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Chung Seung, Minister of Food and Drug Safety of the Republic of Korea. Both sid2013/12/31
-
FDA says nada to Lemtrada; will Sanofi be willing to invest in additional trials?Sanofi ($SNY) intends to appeal the FDA's denial ofLemtrada, itsmultiple sclerosisdrug that was a key reason it paid $20.1 billion to buy Genzyme two years ago. But the question burning in the mind of2013/12/31
-
Aptalis files IPO after owner TPG Capital couldn't find a buyerPrivate investment firms buy up drug companies with the idea of cashing out at some point with a big profit.TPG Capital, unable to find a buyer willing to pay its $3 billion-plus asking price forAptal2013/12/30